Viewing Study NCT01008566


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-01-27 @ 7:53 AM
Study NCT ID: NCT01008566
Status: COMPLETED
Last Update Posted: 2016-05-12
First Post: 2009-11-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Hepatocellular Carcinoma View
None Advanced Adult Hepatocellular Carcinoma View
None Localized Non-Resectable Adult Liver Carcinoma View
None Recurrent Adult Liver Carcinoma View
Keywords: